r.rotation.to⌕ Search stocks, people, sectors
Request a free account

Follow the people · Insider

JR

Jason P. Rhodes

Insider · Director · DYN

Jason P. Rhodes files insider transactions with the SEC as a director of Dyne Therapeutics (DYN). We hold 19 disclosed purchases and sales filed since 3 July 2013, 9 of them in the last 90 days.

  • Files forDYN
  • Disclosed buys and sells19 in all, 9 in the last 90 days
  • Last disclosure17 August 2026

Positions held

5 posts we hold — a term names its own dates; a run of filings only says when they filed
  • Filed 21 September 2020 — 14 August 2026Director · Dyne Therapeutics (DYN)126 Form 4 lines · source: SEC Form 4
  • Filed 11 June 2020 — 9 February 2026Director · Generation Bio Co (GBIO)68 Form 4 lines · source: SEC Form 4
  • Filed 24 July 2018 — 1 April 2022Director · Replimune Group (REPL)81 Form 4 lines · source: SEC Form 4
  • Filed 4 October 2021 — 4 October 2021Director and 10% owner · Gemini Therapeutics, Inc. /DE (GMTX)1 Form 4 line · source: SEC Form 4
  • Filed 1 July 2013 — 22 September 2014President, CFO and Treasurer · Epizyme (EPZM)46 Form 4 lines · source: SEC Form 4

Everything they disclosed

120 entries, newest first — one per disclosure report, one per Form 4 line

Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.